Sean

Author's details

Name: Sean Ekins
Date registered: April 7, 2011

Latest posts

  1. Voucher roller coaster ride — April 18, 2018
  2. Getting to an in vivo active compound — December 7, 2017
  3. Seeing through the hype of deep learning for drug discovery — June 26, 2017
  4. A Dying Breed — May 25, 2017
  5. Summer intern for Collaborations Pharmaceuticals — April 20, 2017

Most commented posts

  1. Beware Rare Disease Foundations – Funding Scam — 16 comments
  2. Collaboration could give us a gold standard database of drugs — 15 comments
  3. Green Chemistry – Solvent selection guide — 11 comments
  4. Lets do it all again updating predictions for the ‘real’ BIA 10-2474 — 10 comments
  5. Survey Overload for Scientists – A Language Discrimination Survey — 9 comments

Author's posts listings

Apr
18

Voucher roller coaster ride

Its been a while since my last post here but its getting harder to find time between the 2 companies and writing grants. But one of the most interesting things I have been watching has been the roller coaster ride of the Pediatric Rare Disease priority review vouchers over a few years. The most recent …

Continue reading »

Dec
07

Getting to an in vivo active compound

Its been an incredibly fast paced year and hence my posting frequency has suffered. Perhaps its time to get back to writing . Today we had a press release with SRI so that triggered me to fill in the back story. Rewind back to 2014 and the Ebola outbreak was in full flow – see …

Continue reading »

Jun
26

Seeing through the hype of deep learning for drug discovery

The frequency seems to be increasing where I see something that sets me off (head in hands saying why, why why?)..Over the past few years I have seen AI/ Deep Learning and drug discovery appearing often and that may not be a good thing. Now this could be the PR engines of the VC’s, companies …

Continue reading »

May
25

A Dying Breed

If you have ever wondered how the pill you are taking for your disease originated, then nowadays you don’t have to go far to find out, as a quick search of Wikipedia will return the molecule, who makes it, and a wide array of prescribing information and warnings. This has not always been the case, …

Continue reading »

Apr
20

Summer intern for Collaborations Pharmaceuticals

We are seeking a Biochemist or Chemist (Masters/PhD) for a summer intern assignment in our Raleigh NC offices.  The duties of the scientist will be to assist with expert data curation for computational modelling of rare and neglected diseases. This position is ideal for a Masters or PhD student in the RTP or Triad area …

Continue reading »

Mar
16

Drug Discovery Today Special Issue on Tuberculosis

Today a special issue of Drug Today Today was published. I was  the editor of this issue and honored that so many colleagues from our European funded MM4TB and other European projects agreed to provide articles on their contributions to Tuberculosis drug discovery. Through collaborations I was directly involved in providing 3 articles and an …

Continue reading »

Mar
09

A bit of an update on Collaborations Pharmaceuticals

Its been a few months since the last post. In that time Collaborations Pharmaceuticals has been working flat out. We hired a Postdoc and associate and have been keeping our heads down working on the 3 NIH grants with collaborators. Next week I will be representing the team at the Gordon Conference on Tropical infectious diseases and …

Continue reading »

Jan
18

Post doctoral position on chaperone development for neurological disorders

I would like to highlight an open postdoc position in the lab of a close collaborator Dr. Alexey Pshezhetsky Open position: Postdoctoral fellow or Ph.D. student Supervising researcher and laboratory: Dr. Alexey Pshezhetsky, laboratory studying lysosomal biology and metabolic disorders, Research Center of CHU Sainte-Justine Project length: 1 year with renewal opportunity Start date: Immediately …

Continue reading »

Dec
20

Small Molecule Bioactivity Databases Book Chapter

Its been a busy year transitioning from spending most of my time with CDD to my start-up Collaborations Pharmaceuticals, Inc etc. Along the way I found time to write a few book chapters. One of these recently published in High Throughput Screening Methods : Evolution and Refinement Editors: Joshua A Bittker, Nathan T Ross Our …

Continue reading »

Dec
16

Collaborations Pharmaceuticals, Inc. Announce NIH Award to Develop New Software for Drug Discovery

Today I released the following Collaborations Pharmaceuticals Inc, announcement of our 3rd NIH grant this year. This is an SBIR and will fund software development to provide a tool the company will be able to use in its drug discovery programs but also make commercially available. It will build off our past publications on open …

Continue reading »

Older posts «